Phenotypic Characterization of Circulating CD4+ T Cells in ANCA-Associated Vasculitis
Table 3
Concentrations of CD4+ T cell-related cytokines and chemokines in plasma from patients with ANCA-associated vasculitis (AAV) and healthy blood donors (HBD).
IFN-γ
CXCL9
IL-4
CCL22
IL-23
IL-17A
CCL20
AAV
13.6 (12.8, 14.6)
61.5 (38.9, 79.7)
6.21 (6.21, 7.19)
248.1 (171.2, 398.8)
53.8 (50.3, 57.3)
7.51 (7.10, 8.44)
28.6 (21.4, 39.5)
Active AAV
13.6 (12.8, 14.4)
60.4 (43.4, 65.0)
6,21 (4.43, 7.0)
221.4 (34.9, 248.1)
52.6 (50.3, 57.3)
7.92 (7.10, 8.23)
35.8 (28.6, 37.2)
Inactive AAV
13.8 (12.8, 14.8)
64.0 (37.0, 80.1)
6,66 (6.21, 7.32)
258.3 (174.8, 507.2)
53.5 (50.3, 57.3)
7.46 (7.07, 8.64)
21.3 (21.3, 0.434)
GPA
13.2 (12.8, 14.4)
51.8 (37.0, 69.1)
7.10 (6.21, 7.55)
239.9 (190.7, 359.8)
53.8 (50.9, 57.3)
7.82 (7.20, 8.64)
25.3 (18.5, 35.8)
MPA
14.0 (12.9, 16.0)
72.5 (56.1, 117.4)
6.21 (5.10, 6.43)
258.3 (73.3, 647.9)
53.8 (50.3, 60.9)
7,05 (7.00, 8.15)
38.2 (30.5, 74.1)
HBD
12.8 (12.2, 13.2)
22.1 (19.5, 30.4)
6.21 (6.21, 7.99)
252.2 (180.4, 307.5)
53.8 (50.3, 56.1)
7.72 (7.20, 8.18)
16.2 (15.0, 18.1)
Concentrations are measured in pg/mL. Figures represent median with interquartile ranges. and , when compared with HBD.
